Literature DB >> 22914474

Preventing maternal and newborn deaths globally: using innovation and science to address challenges in implementing life-saving interventions.

Herbert B Peterson1, Joumana Haidar, Mario Merialdi, Lale Say, A Metin Gülmezoglu, Peter J Fajans, Michael T Mbizvo, Abdul Ghaffar, Nhan T Tran, Luc de Bernis, Laura Laski, Lynn P Freedman, Mickey Chopra.   

Abstract

We have made important progress toward achieving Millennium Development Goals 4 and 5, with an estimated 47% decrease in maternal deaths and 28% decrease in newborn deaths globally since 1990. However, rapidly accelerating this progress is vital because far too many maternal and newborn deaths still occur each day. Fortunately, there are major initiatives underway to enhance global efforts in preventing these deaths, including the United Nations Secretary General's Global Strategy for Women's and Children's Health. We know why maternal and newborn deaths occur, where they occur, and how they occur, and we have highly effective interventions for preventing them. Nearly all (99%) maternal and newborn deaths occur in developing countries where the implementation of life-saving interventions has been a major challenge. Determining how best to meet this challenge will require more intensive interrelated efforts that include not only science-driven guidance on effective interventions, but also strategies and plans for implementing these interventions. Implementation science, defined as "the study of methods to promote the integration of research findings and evidence into healthcare policy and practice," will be key as will innovations in both technologies and implementation processes. We will need to develop conceptual and operational frameworks that link innovation and implementation science to implementation challenges for the Global Strategy. Likewise, we will need to expand and strengthen close cooperation between those with responsibilities for implementation and those with responsibilities for developing and supporting science-driven interventions. Realizing the potential for the Global Strategy will require commitment, coordination, collaboration, and communication-and the women and newborns we serve deserve no less.

Entities:  

Mesh:

Year:  2012        PMID: 22914474     DOI: 10.1097/AOG.0b013e3182632cc1

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  6 in total

1.  Maternal and newborn health implementation research: programme outcomes, pathways of change and partnerships for equitable health systems in Uganda.

Authors:  Asha George; Moses Tetui; George W Pariyo; Stefan S Peterson
Journal:  Glob Health Action       Date:  2017-08       Impact factor: 2.640

2.  Maternal mortality and morbidity burden in the Eastern Mediterranean Region: findings from the Global Burden of Disease 2015 study.

Authors: 
Journal:  Int J Public Health       Date:  2017-08-03       Impact factor: 3.380

3.  mHealth tool to improve community health agent performance for child development: study protocol for a cluster-randomised controlled trial in Peru.

Authors:  Christopher Michael Westgard; Natalia Rivadeneyra; Patricia Mechael
Journal:  BMJ Open       Date:  2019-11-06       Impact factor: 2.692

4.  A Cross-Sectional Study of Antenatal Care Attendance among Pregnant Women in Western Jamaica.

Authors:  Ebony Townsend Respress; Pauline E Jolly; Chinye Osia; Nichole Dawson Williams; Swati Sakhuja; Suzanne E Judd; Maung Aung; April P Carson
Journal:  J Pregnancy Child Health       Date:  2017-07-31

5.  Implementation outcomes of the national scale up of chlorhexidine cord cleansing in Bangladesh's public health system.

Authors:  Jennifer A Callaghan-Koru; Marufa Khan; Munia Islam; Ardy Sowe; Jahurul Islam; Sk Masum Billah; Imteaz Ibne Mannan; Joby George
Journal:  J Glob Health       Date:  2019-12       Impact factor: 4.413

6.  The Use of Implementation Science Tools to Design, Implement, and Monitor a Community-Based mHealth Intervention for Child Health in the Amazon.

Authors:  Christopher Westgard; W Oscar Fleming
Journal:  Front Public Health       Date:  2020-08-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.